Danaher

Danaher is a global leader in life sciences and diagnostics, committed to advancing human health through innovative technologies and services.

Danaher Overview

Danaher is a global leader in the life sciences and diagnostics industries. The company focuses on accelerating scientific and technological advancements to improve human health. Headquartered in Washington, DC, Danaher operates with a strong global presence through its regional offices. The Danaher Business System (DBS) guides the company's culture and performance, ensuring consistent and effective operations across all its segments.

Danaher Biotechnology

Danaher's Biotechnology business offers extensive expertise, technologies, and services to speed up the development and commercialization of transformative therapies. Led by Cytiva, this segment assists researchers and biopharmaceutical producers by providing essential tools and expert support. By fostering advancements in cell and gene therapies and molecular oncology, Danaher's Biotechnology segment is instrumental in shaping the future of healthcare.

Danaher Diagnostics

Danaher's Diagnostics businesses create cutting-edge tools and software aimed at enhancing the accuracy and speed of medical diagnoses. Operating on six continents, these businesses utilize digital data to facilitate precision diagnostics. A notable effort within this segment includes Beckman Coulter's development of a new system with 100 times the sensitivity of previous immunoassay platforms, paving the way for significant improvements in diagnostic capabilities.

Danaher Life Sciences

Danaher's Life Sciences businesses provide powerful tools and technologies to support critical activities in scientific research. This segment aids customers in developing breakthrough innovations, such as sophisticated biopharmaceuticals and advanced synthetic biologics. By collaborating with top academic institutions, Danaher fosters research and development, enabling the creation of technologies that drive advances in healthcare and related fields.

Danaher Sustainability and Inclusion

Danaher's sustainability strategy is centered on innovating products that benefit both lives and the environment. The company is committed to maintaining pay equity, having achieved it in the U.S. since 2020. Danaher also promotes diversity, equity, and inclusion through several Associate Resource Groups (ARGs). The company's sustainability report outlines its progress and priorities in these areas, underscoring its dedication to building a better and more inclusive future. One of Danaher's notable projects includes developing a blood test for Alzheimer's disease with improved sensitivity for early detection.

Companies similar to Danaher